Ensign Peak Advisors’s Disc Medicine IRON Stock Holding History

Ensign Peak Advisors’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.93M	Sell	122,111 -69,376	-36%	-$4.77M	0.01%	457
2026 Q1	$12.2M	Buy	191,487 +14,437	+8%	+$1M	0.02%	374
2025 Q4	$14.1M	Hold	177,050	–	–	0.02%	342
2025 Q3	$11.7M	Buy	177,050 +35,505	+25%	+$2.11M	0.02%	422
2025 Q2	$7.5M	Buy	141,545 +69,032	+95%	+$3.24M	0.01%	547
2025 Q1	$3.6M	Buy	72,513 +32,513	+81%	+$1.81M	0.01%	712
2024 Q4	$2.54M	Hold	40,000	–	–	﹤0.01%	841
2024 Q3	$1.97M	Hold	40,000	–	–	﹤0.01%	966
2024 Q2	$1.8M	Hold	40,000	–	–	﹤0.01%	961
2024 Q1	$2.49M	Hold	40,000	–	–	﹤0.01%	842
2023 Q4	$2.31M	Hold	40,000	–	–	﹤0.01%	859
2023 Q3	$1.88M	Hold	40,000	–	–	﹤0.01%	856
2023 Q2	$1.78M	Buy	+40,000	New	+$1.42M	﹤0.01%	925

Other funds holding IRON

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ensign Peak Advisors's IRON Position: Q2 2026 in Review

Ensign Peak Advisors reduced its Disc Medicine (IRON) stake by 36% in Q2 2026, selling an estimated $4.77M and leaving 122,111 shares worth $8.93M. The position accounts for 0.01% of the portfolio, ranked #457.

Ensign Peak Advisors first reported a position in IRON in Q2 2023 and has held it in 13 quarters since. The position peaked at $14.1M in Q4 2025. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

Ensign Peak Advisors held 122,111 shares of Disc Medicine worth $8.93M as of Q2 2026.
Ensign Peak Advisors sold 69,376 Disc Medicine shares in Q2 2026, an estimated $4.77M.
Disc Medicine made up 0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #457 holding.
Ensign Peak Advisors first reported a position in Disc Medicine in Q2 2023 and has held it in 13 quarters since.
Ensign Peak Advisors's Disc Medicine position peaked at $14.1M in Q4 2025.
215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.